Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Attilio Olivieri"'
Autor:
Vladimir Perovic, Ivan Sabol, Magdalena Grce, Marit Inngjerdingen, Drazen Pulanic, Zinaida Peric, Christophe Peczynski, Emmanuelle Polge, Christian Koenecke, Anne Dickinson, Hildegard Greinix, Grzegorz Basak, Olaf Penack, Angela Scherwath, Anna Barata, Attilio Olivieri, Anita Lawitschka, Patrycja Mensah-Glanowska, Hajnalka Andrikovics, Helene Schoemans, Daniel Wolff
Publikováno v:
Bone Marrow Transplantation
Background Chronic graft-versus-host disease (cGvHD) is one of the most common life-threatening complications following allogeneic haematopoietic stem cell transplantation (alloHSCT). Understanding outcome after alloHSCT requires a full evaluation of
Autor:
Raynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, Didier Blaise, Anna Maria Raiola, Jiri Pavlu, Luca Castagna, Gerard Socié, Yves Chalandon, Massimo Martino, Friedrich Stölzel, Gesine Bug, Benedetto Bruno, Radovan Vrhovac, Amandine Charbonnier, Attilio Olivieri, Jacques-Olivier Bay, Herrera Arroyo, Ibrahim Yakoub-Agha, Daniele Avenoso, Andreas Neubauer, Stéphanie Nguyen, Edouard Forcade, Eolia Brissot, Bipin Savani, Arnon Nagler, Mohamad Mohty
The optimal conditioning regimen prior haploidentical stem cell transplantation (Haplo-SCT) with post transplantation cyclophosphamide (PT-Cy) for acute myeloid leukemia (AML) remains unknown. A non-myeloablative conditioning (NMAC) regimen (cyclopho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65f28dcbae99b364c6b9df908fa9355f
https://www.bib.irb.hr/1274555
https://www.bib.irb.hr/1274555
Autor:
Chiara Nozzoli, Simona Bassi, Adriana Vacca, Carlo Borghero, Paola Carluccio, Vicky Rubini, Sonia Mammoliti, Nicoletta Sacchi, Patrizia Chiusolo, Carmine Selleri, Attilio Olivieri, Elena Oldani, Anna Paola Iori, Anna Proia, Sadia Falcioni, Luisa Giaccone, Patrizio Mazza, Massimo Martino, Vincenzo Pavone, F Bonifazi, Giovanni Grillo, Benedetto Bruno, Cristina Skert, Francesco Onida, Mario Luppi, Fabio Ciceri, Francesca Patriarca, Annalisa Natale, Marco Casini, Nicola Polverelli, Marco De Gobbi, Michele Malagola, Angelo Michele Carella, Stefania Bramanti, Elisabetta Terruzzi, Paolo Bernasconi, Domenico Russo
Today, allogeneic stem cell transplantation (allo-SCT) can be offered to patients up to age 70 to 72 years and represents one of the most effective curative treatments for many hematologic malignancies. The primary objective of the study was to colle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d9a92c7520e0c54cf4cb96ddcd20cd2
https://hdl.handle.net/11380/1280517
https://hdl.handle.net/11380/1280517
Autor:
Anna Paola Iori, Federica Sorà, Emanuele Angelucci, Carmen Di Grazia, Andrea Bacigalupo, Attilio Olivieri, Anna Maria Raiola, Patrizia Chiusolo, Alessandro Rambaldi, Simona Sica, Elisabetta Terruzzi, Francesca Patriarca, Sigal Grisariu, Nicola Mordini, Benedetto Bruno, Stefania Bregante
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:698-703
This is a multicenter retrospective comparison of 2 myeloablative conditioning regimens in 454 patients with acute myeloid leukemia (AML) in remission: busulfan (4 days) and fludarabine (BUFLU) versus thiotepa, busulfan, and fludarabine (TBF). Eligib
Autor:
Michael Potter, Meral Beksac, Patrick Hayden, Uwe Platzbecker, Stephanie Nguyen-Quoc, Linda Koster, William Arcese, Alida Dominietto, Nicolaas Schaap, Monique C. Minnema, Edouard Forcade, Dirk Jan Eikema, Johanna Tischer, Virginie Gandemer, Ibrahim Yakoub-Agha, Hermann Einsele, Nicolaus Kröger, Angelo Michele Carella, Liesbeth C. de Wreede, Fabio Ciceri, Per Ljungman, Joan Hendrik Veelken, Jacob Passweg, Laure Vincent, Arancha Bermúdez, Adrian Bloor, Stefan Schönland, Attilio Olivieri
Publikováno v:
Bone Marrow Transplantation, 56, 2367-2381
Bone Marrow Transplantation, 56, 10, pp. 2367-2381
Bone Marrow Transplantation, 56(10), 2367-2381. SPRINGERNATURE
Bone Marrow Transplantation
Bone Marrow Transplantation, 56, 10, pp. 2367-2381
Bone Marrow Transplantation, 56(10), 2367-2381. SPRINGERNATURE
Bone Marrow Transplantation
The EBMT Chronic Malignancies Working Party performed a retrospective analysis of 215 patients who underwent a second allo-HCT for myeloma between 1994 and 2017, 159 for relapse and 56 for graft failure. In the relapse group, overall survival (OS) wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::576c8e78782023de844351453f89f092
http://hdl.handle.net/2066/244085
http://hdl.handle.net/2066/244085
Autor:
Raynier Devillier, Didier Blaise, Armando Santoro, Maria Raiola Anna, Andrea Bacigalupo, Roberto Raimondi, William Arcese, Barbara Sarina, Luca Castagna, Alessandro Busca, Carmelo Carlo-Stella, Daniele Vallisa, Francesca Patriarca, Fabio Ciceri, Michele Malagola, Paolo Corradini, Laura Giordano, Stefania Bramanti, Francesca Bonifazi, Reda Bouabdallah, Jacopo Mariotti, Attilio Olivieri, Alessandro Rambaldi, Sabine Furst, Giorgina Specchia
Publikováno v:
BMC Cancer
Background Allogeneic stem cell transplantation from haploidentical donor using an unmanipulated graft and post-transplantation cyclophosphamide (PT-Cy) is growing. Haploidentical transplantation with PT-Cy showed a major activity in Hodgkin lymphoma
Autor:
Goda Choi, Riitta Niittyvuopio, Edouard Forcade, Nicolaus Kröger, Jan J. Cornelissen, Tony Marchand, Mohamad Mohty, Arnon Nagler, Didier Blaise, Ali Bazarbachi, Attilio Olivieri, Gérard Socié, Hélène Labussière-Wallet, Myriam Labopin, Jenny Byrne, Bipin N. Savani, Gaelle Guillerm, Francesco Saraceni, Jordi Esteve
Publikováno v:
Cancer Medicine
Cancer Medicine, Wiley, 2021, 10 (1), pp.23-33. ⟨10.1002/cam4.3593⟩
Cancer medicine, 23-33. Wiley
ISSUE=1;STARTPAGE=23;ENDPAGE=33;ISSN=2045-7634;TITLE=Cancer medicine
Cancer Medicine, 2021, 10 (1), pp.23-33. ⟨10.1002/cam4.3593⟩
Cancer Medicine, 10(1), 23-33. John Wiley & Sons Ltd.
Cancer Medicine, Wiley, 2021, 10 (1), pp.23-33. ⟨10.1002/cam4.3593⟩
Cancer medicine, 23-33. Wiley
ISSUE=1;STARTPAGE=23;ENDPAGE=33;ISSN=2045-7634;TITLE=Cancer medicine
Cancer Medicine, 2021, 10 (1), pp.23-33. ⟨10.1002/cam4.3593⟩
Cancer Medicine, 10(1), 23-33. John Wiley & Sons Ltd.
Limited data are currently available on the outcome of patients with acute myeloid leukemia (AML) undergoing allogeneic stem cell transplantation (allo‐SCT) with a reduced performance status. We herein present the results of a registry study on 2,9
Autor:
Federica Giantomassi, Ilaria Scortechini, Pietro Leoni, Giorgia Mancini, Gaia Goteri, Martina Chiarucci, Jacopo Olivieri, Attilio Olivieri
Publikováno v:
Leukemia & Lymphoma. 57:965-968
Graft failure (GF) after allogeneic stem cell transplantation (SCT) is a serious complication with high mortality. Graft rejection and poor graft function (PGF) are common causes of GF and they can...
Autor:
Filippo Gherlinzoni, Maria Chiara Tisi, Irene Federici, Giulia Perali, Nicola Cascavilla, Francesco Saraceni, Gabriella Tomei, Anna Maria Mazzone, Federico Mosna, Jacopo Olivieri, Enrico Orciuolo, Simone Ferrero, Piero Maria Stefani, Giuseppe Carli, Paola Ghione, Francesco Lanza, Matteo Pelosini, Margherita Giannoccaro, Silvia Finotto, Renato Fanin, Katia Codeluppi, T. Calimeri, Atto Billio, Patrizia Chiusolo, Carlo Borghero, Giacomo Loseto, Sara Rattotti, Dario Marino, Riccardo Centurioni, R. Matera, Nicola Sgherza, Simona Sica, Attilio Olivieri, Angelo Fama, Francesco Zaja
BEAM (carmustine [bis-chloroethylnitrosourea (BCNU)]-etoposide-cytarabine-melphalan) chemotherapy is the standard conditioning regimen for autologous stem cell transplantation (ASCT) in lymphomas. Owing to BCNU shortages, many centers switched to fot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f43964691f54b348275cca237ce2efb8
http://hdl.handle.net/11392/2415902
http://hdl.handle.net/11392/2415902
Autor:
Vittorio Montefusco, Cristiana Carniti, Attilio Olivieri, Alessandro Rambaldi, Francesco Maura, Lucia Farina, Barbara Sarina, Luisa Roncari, Francesco Onida, Francesco Zallio, Anna Dodero, Francesco Spina, Paolo Corradini, Francesca Patriarca, Jacopo Mariotti
Publikováno v:
Biology of Blood and Marrow Transplantation. 20:885-890
Cytomegalovirus (CMV) replication after allogeneic hematopoietic stem cell transplantation (HSCT) was historically associated with increased nonrelapse mortality (NRM). More recently, different groups have reported an association between CMV replicat